THMO Cesca Therapeutics Year-over-year net earnings per share growth for the last 12 months
ThermoGenesis is implementing advanced biobanking and stem cell processing methods. A closed ecosystem featuring proprietary cartridges and FDA protection ensures high B2B customer loyalty. The quarterly EPS trend reflects the result of this synergy, with the current figure standing at 87.90. However, a prolonged liquidity shortage and uncertainty regarding the long-term course create challenges for management in monetizing software.
Comprehensive metric breakdowns and analytics for Cesca Therapeutics (THMO)
- share price and expert price forecast:
- market capitalization data:
- book capitalization indicators:
- business debt structure and liquidity details:
Total Debt to Capital ThermoGenesis|THMO - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital ThermoGenesis|THMO - Company Total Debt Obligations|Debts to Book Capitalization ThermoGenesis Holdings Inc.|THMO - Company Long-Term Liabilities|Company Short-Term Debts ThermoGenesis|Quick Liquidity thermogenesis.com
- earnings and market multiples details:
THMO - Company Net Income|Future Profit ThermoGenesis|THMO - Company Value to Net Income|Forward P/E Multiple ThermoGenesis Holdings Inc.|THMO - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ThermoGenesis Holdings Inc.|THMO - Operating profit before depreciation charges|Net earnings per share for the last 12 months ThermoGenesis|THMO - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth thermogenesis.com|THMO - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year ThermoGenesis
Analysis of all company metrics:ThermoGenesis Holdings - THMO
To find a balance between asset cost and quality, evaluate the net income per share trend, which eliminates manipulative distortions and reveals real operational efficiency through the daily recording of quarterly changes. In the case of ThermoGenesis (THMO), this quarterly net income per share growth metric reflects the conversion of the installed equipment base into a stable cash flow from the sale of consumables.
Main competitors
ABT: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Thermo Fisher Scientific Inc.|Year-over-year net earnings per share growth for the last 12 months GEHC|MTD: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Waters Corporation (WAT)|Year-over-year net earnings per share growth for the last 12 months bio-techne.com TECH|Quarterly EPS earnings growth BRKR (Bruker)|Azenta Inc (AZTA) - Earnings per share growth in annualized terms for the last twelve months|Varex - Quarterly EPS earnings growth|SMLR (Semler) - Year-over-year earnings per share growth for the last 12 months|BFLY: Quarterly EPS earnings growth|MLAB - Year-over-year net earnings per share change for the last twelve months|QSI (Quantum-Si Incorporated) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Nano-X Imaging (NNOX)|Quarterly EPS earnings growth QTRX|Quarterly EPS earnings growth 908 Devices Corporation (MASS)|Year-over-year earnings per share growth for the last twelve months CapsoVision CV|maxcyte.com - Year-over-year earnings per share growth for the last twelve months|RPID: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months SEER (Seer Inc)|HYPR: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months FONAR Corporation Inc (FONR)|Year-over-year earnings per share growth for the last twelve months Daxor Corp|MDAI - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months VIVS (organovo.com)|Quarterly EPS earnings growth Aclarion Inc (ACON)|Quarterly EPS earnings growth AKYA (Akoya Biosciences, Inc.)|Year-over-year net earnings per share change for the last twelve months Talis Biomedical Corp. (TLIS)|TTOO - Year-over-year earnings per share growth for the last twelve months
